PCT Protocol: The Complete Post-Cycle Therapy Guide
PCT · 11 min read · Updated on May 23, 2026
Post-cycle therapy (PCT) is the set of actions you take to restart natural testosterone production after a cycle. While on cycle, exogenous testosterone fully shuts down the hypothalamic-pituitary-testicular axis (HPTA) — it is mechanical and shows up on any mid-cycle blood panel. That shutdown does not lift on its own when the last injection lands: without an active PCT, the axis can take months to come back online, sometimes longer.
This guide is the head of the PCT cluster. It lays out the logic: why PCT is non-negotiable, what the modern tools actually do (Nolvadex, Clomid, HCG), when to start based on the ester you ran, what a sample protocol looks like, and how to confirm recovery actually happened. For deeper breakdowns, this page hands off to the supporting guides: Nolvadex vs Clomid, HCG on cycle and PCT, when to start PCT, and PCT after SARMs.
Why a PCT is non-negotiable
Testosterone is regulated by a negative feedback loop. The hypothalamus releases GnRH, which prompts the pituitary to produce LH and FSH, which in turn drive testicular testosterone production and spermatogenesis. When serum testosterone climbs (under exogenous gear), the brain reads that the target is hit and cuts the signal: LH and FSH collapse, testicular production stops, and the testicles atrophy over the weeks that follow [1].
Once the cycle ends, the exogenous level drops back down, but the HPTA stays 'off' through inertia. Until something restores the signal, endogenous production does not restart. Without an active PCT, the user goes through a window of post-cycle hypogonadism: dead libido, persistent fatigue, low mood, rapid loss of part of the gains — sometimes for months [5].
What a PCT is actually trying to achieve
- Restart pituitary secretion of LH and FSH — that is what SERMs do.
- Wake up the testicular Leydig cells if they have been dormant for too long — that is the optional role of HCG before the PCT itself.
- Hold on to as many cycle gains as possible by keeping the hormonal environment favorable to muscle retention.
- Confirm recovery with a follow-up blood panel 4 to 6 weeks after the end of PCT.
The PCT toolkit: SERMs, HCG, AI
Three families of compounds structure modern PCT. Each has a precise role: mixing them up is the classic mistake that makes a PCT ineffective.
SERMs: Nolvadex and Clomid
SERMs (selective estrogen receptor modulators) block estradiol at the hypothalamic and pituitary level. The brain stops "seeing" estradiol the way it did, reads that as a low-level signal, and restarts GnRH secretion — then LH and FSH. The two SERMs used in PCT are Nolvadex (tamoxifen) and Clomid (clomiphene). The full trade-offs — potency, side effects, which one when — sit in the Nolvadex vs Clomid guide.
HCG: a distinct tool, used at the right moment
HCG mimics LH and acts directly on the testicles. Its role is not to restart the HPTA — on the contrary, HCG keeps central signaling suppressed for as long as you are on it. Its place is in two windows: on cycle to preserve testicular volume and sensitivity [2], or as a short pre-PCT primer if atrophy is marked and the cycle was long. HCG does not get run during PCT itself: that would be counterproductive. Details in the HCG on cycle and PCT guide.
AI in PCT: yes but with restraint
During PCT, running a SERM can indirectly let estradiol climb (estradiol is a normal byproduct of testosterone, and endogenous testosterone is coming back up). A blood measurement of estradiol stays the foundation: a very low-dose AI (anastrozole or exemestane) only gets introduced if values run out of range with clinical signs. Crashing estradiol during PCT is the classic mistake that ruins well-being recovery and amplifies gain loss. See the aromatase inhibitors on cycle guide.
When to start PCT: it all depends on the ester
PCT timing is dictated by the kinetics of the longest compound in the cycle. Starting PCT too early — when the exogenous level is still high — neutralizes the SERMs: the brain is still "seeing" an anabolic signal and has no reason to restart. Starting too late, on the other hand, drags the hypogonadism window out unnecessarily. The principle: wait until residual levels are low enough that SERMs can actually act.
| Ester / compound | Half-life | Delay before PCT |
|---|---|---|
| Propionate (Test P) | 2 days | 3 to 5 days after the last injection |
| Enanthate (Test E), Cypionate (Test C) | 4.5 to 5 days | Roughly 2 weeks after the last injection |
| Nandrolone decanoate (Deca) | 6 days | 3 weeks, sometimes longer depending on accumulated dose |
| Boldenone undecylenate (EQ) | 14 days | 3 to 5 weeks depending on cycle length |
| Trenbolone acetate | 1 day | 3 to 5 days after the last injection |
For the fine-grained calculation and a visual of serum decay day by day, see the half-life calculator, and the when to start PCT guide for the detailed mechanics of the "time off" window.
Sample protocols: SERM-only, combined SERMs, HCG primer
Three protocols cover the vast majority of situations. The choice depends on cycle length, the compounds used and the expected severity of suppression. Doses cited match the ranges in AnaProtoKol's compound pages — read those pages for the full ranges by experience level.
Protocol 1 — Nolvadex only (short to standard testosterone-only cycle)
- Classic scheme: 40/40/20/20 mg/day over 4 weeks.
- Softer variant, better tolerated by users sensitive to SERMs: 20/20/20/20 mg/day over 4 weeks.
- Start: based on the ester (see table above).
- Profile: first pick for a first cycle or for a standard testosterone-only cycle at a contained dose.
Protocol 2 — Clomid only (deeper suppression)
- Classic scheme: 50/50/25/25 mg/day over 4 weeks.
- Stronger scheme for severe suppression (long Deca, long cycles): 100/50/50/25 mg/day over 4 weeks.
- Profile: for cycles where suppression runs deeper (long cycles, deca, sustained tren), at the cost of more frequent side effects (visual disturbances, mood).
Protocol 3 — Nolvadex + Clomid combined (severe suppression)
- Nolvadex 20 mg/day + Clomid 50 mg/day over the first 4 weeks, then Nolvadex 20 mg/day alone for 2 more weeks.
- Profile: long cycles, blast, return to PCT after a cruise period, or any cycle that included trenbolone at intermediate to high dose.
Protocol 4 — HCG primer, then SERMs (long cycle or marked atrophy)
- HCG in a short course before PCT: e.g. 2000 IU every other day over 2 to 3 weeks (or a lighter scheme per the HCG compound page), to wake up the Leydig cells.
- SERMs (Nolvadex or Nolvadex + Clomid) kick in at the end of the HCG course.
- HCG stops BEFORE PCT — not in parallel. See the HCG on cycle and PCT guide.
What happens during PCT and how to ride it out
The first weeks of PCT are rarely euphoric. Exogenous levels have dropped, endogenous has not climbed back yet, and the body is crossing a hormonal valley. Knowing that ahead of time keeps you from panicking and sabotaging the protocol.
What to expect
- Drop in libido and varying levels of fatigue, especially over the first 2 to 3 weeks.
- Slight mass loss — mechanical, especially the water retention component. Strength drops more slowly than mass, as long as you keep training seriously.
- Variable mood, sometimes a sense of emotional 'flatness'. The SERM can amplify that, particularly with Clomid.
- Testicular volume coming back gradually over 4 to 8 weeks.
What actually helps
- Keep training and nutrition dialed in. Skipping the gym 'because you're tired' speeds up mass loss.
- Max sleep, minimum stress: those are the variables driving cortisol, which is the direct enemy of hormonal recovery.
- Run the protocol all the way through — do not cut it short 'because you feel better.'
- Do not start a new cycle at the first sign of lingering fatigue — wait for the follow-up blood panel.
Post-PCT blood work: the only proof of recovery
Subjective feel does not validate recovery. A user can feel 'fine' with an LH of 1 and a testosterone of 350 ng/dL — that is still flat-out hypogonadism. Conversely, a user in real recovery may still have low libido 4 weeks post-PCT simply because the estradiol peak has not rebalanced yet. Only bloods settle it [4].
When and what to measure
- Timing: 4 to 6 weeks after the last SERM dose [3].
- Markers: total and free testosterone, LH, FSH, estradiol (sensitive E2), SHBG. Add CBC, lipid panel, liver panel if orals were used. Details in the hormonal markers on cycle guide.
- Reading reference: come back inside your personal baseline range (measured before the cycle), not just 'inside the lab range.'
If the numbers do not come back
If at 6 to 8 weeks post-PCT testosterone is still low and LH/FSH have not climbed, recovery is incomplete [6]. Possible causes: bad PCT timing, insufficient SERM dose, a cycle more suppressive than expected (Deca, long trenbolone), or individual predisposition. In that case, the right move is to stop cycling, see an endocrinologist or a physician trained in post-AAS hypogonadism management, and absolutely do not start a new cycle to "mask" the trough. The full follow-up calendar is detailed in blood test schedule on cycle.
Edge cases: SARMs, blast and cruise, TRT
PCT after SARMs
SARMs suppress the HPTA — not always to the depth of a steroid cycle, but really and measurably. Common practice is a mini-PCT (e.g. Nolvadex 20 mg/day over 4 weeks) after Ostarine, and a full PCT after LGD-4033 or RAD-140. Detail in the do SARMs need a PCT? guide.
Blast and cruise: no PCT, but consequences
In blast and cruise, the user runs no PCT: they alternate high phases (blast) with physiological-dose phases (cruise) without ever stopping exogenous testosterone. It is a choice that amounts to lifelong TRT in practice, with likely irreversible suppression of endogenous production. It is not a shortcut to dodge PCT — it is a distinct path with its own health and fertility implications.
Coming off a cycle into TRT
If after several restart attempts hormonal recovery does not happen, transitioning to medically-supervised TRT can be discussed with an endocrinologist. See the TRT protocol guide. For users wanting to preserve fertility in that context, the role of HCG (and sometimes long monotherapy Clomid) is central: see TRT and fertility.
Frequently asked questions
Is a PCT really mandatory after every cycle?
Yes for any exogenous steroid cycle (testosterone and derivatives) lasting more than a few weeks, and for most anabolic SARMs cycles. HPTA suppression is documented on any mid-cycle blood panel. Without an active PCT, recovery can take months — sometimes longer — with weeks or months of symptomatic hypogonadism. The only credible alternative to PCT is blast and cruise, which is not a shortcut but a choice of permanent TRT.
Nolvadex or Clomid: which one should I pick for PCT?
Nolvadex is the default first pick: softer, better tolerated (rare visual side effects, lower mood impact), effective for the majority of standard cycles. Clomid hits LH/FSH harder and gets used for deeper suppression (long cycles, deca, sustained trenbolone), or combined with Nolvadex. Detail in Nolvadex vs Clomid.
Should I run HCG during PCT?
No. HCG, which mimics LH, keeps central signaling suppressed for as long as you are on it — which is exactly the opposite of what you want during PCT. Its place is either on cycle (to preserve testicular volume) or as a short primer before SERMs kick in if atrophy is marked. HCG gets stopped at least a few days before SERMs start. See HCG on cycle and PCT.
How long after PCT can I start another cycle?
The "time on = time off" rule applies: at least as much time off as you spent under gear. For a 12-week cycle + 4 to 6 weeks of PCT, that means at least 12 weeks of off-time after PCT. And even that is only a minimum if the post-PCT blood panel has not confirmed full recovery (testosterone, LH, FSH back inside your personal baseline). Starting a new cycle on an un-recovered HPTA is stepping onto the blast and cruise slope without owning the choice explicitly.
Sources
Studies and scientific publications this guide relies on.
- Rahnema CD, Lipshultz LI, Crosnoe LE, et al. (2014). Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertility and Sterility. doi: 10.1016/j.fertnstert.2014.02.002
Revue clinique de référence sur l'hypogonadisme induit par les stéroïdes anabolisants (ASIH) : mécanismes de suppression de l'axe HPT, stratégies thérapeutiques (SERM, hCG, AI), schémas de relance, et seuils de basculement vers une prise en charge médicale.
- Coviello AD, Matsumoto AM, Bremner WJ, et al. (2005). Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. Journal of Clinical Endocrinology & Metabolism. doi: 10.1210/jc.2004-0802
RCT chez 29 hommes : 250 UI de hCG tous les deux jours, ajoutées à 200 mg/sem de testostérone énanthate, maintiennent la testostérone intratesticulaire proche du baseline (-7 %) vs effondrement (-57 %) sous testostérone seule.
- Liu PY, Swerdloff RS, Christenson PD, et al. (2006). Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. The Lancet. doi: 10.1016/S0140-6736(06)68614-5
Méta-analyse intégrée de 30 études (1 549 hommes) sur la cinétique de récupération de la spermatogenèse après suppression hormonale par androgènes : médiane de récupération ~3 mois pour la testostérone et la LH, mais 5 à 6 mois pour la production spermatique normale, avec une variabilité individuelle élevée et un effet de la durée d'exposition.
- Anawalt BD (2019). Diagnosis and Management of Anabolic Androgenic Steroid Use. Journal of Clinical Endocrinology & Metabolism. doi: 10.1210/jc.2018-01882
Revue clinique sur l'évaluation et la prise en charge des utilisateurs d'AAS : suppression systématique de l'axe HPT, marqueurs hormonaux à doser (testostérone totale et libre, LH, FSH, œstradiol, SHBG), conduite à tenir en post-cycle et en cas de récupération incomplète.
- Rasmussen JJ, Selmer C, Østergren PB, et al. (2016). Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study. PLoS One. doi: 10.1371/journal.pone.0161208
Étude cas-témoin chez d'anciens utilisateurs d'AAS au long cours : taux de testostérone significativement plus bas et symptômes hypogonadiques des années après l'arrêt, avec une dépendance à l'exposition cumulative.
- Coward RM, Rajanahally S, Kovac JR, et al. (2013). Anabolic steroid induced hypogonadism in young men. Journal of Urology. doi: 10.1016/j.juro.2013.06.010
Série de cas d'hommes jeunes présentant un hypogonadisme induit par les stéroïdes (ASIH) : suppression persistante de l'axe HPT après l'arrêt, parfois durable, justifiant le recours à une TRT à vie chez certains.
Guides liés
Calculateurs utiles
Track your cycle with real data
Daily journal, 52 compounds, blood work and AI analysis — to apply what you just read and track results cycle after cycle.
Free 5-day trial — no credit card